NQMC Update Service: October 26, 2015 ► American Society of Hematology

NQMC Update Service: October 26, 2015

Measure Summaries

American Society of Hematology

• Hematology: percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period. This updates a previously published measure summary.

• Hematology: percentage of patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chart. This updates a previously published measure summary.